Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Journal of Clinical Medicine Research|September 16, 2017
The Low-Dose (7.5 mg/day) Pioglitazone TherapyHidekatsu Yanai, Hiroki Adachi
Journal of Clinical Medicine Research|June 22, 2012
The Underlying Mechanisms for Olanzapine-induced HypertriglyceridemiaHiroki Adachi, Hidekatsu Yanai, Yuji Hirowatari
Cardiology Research|November 21, 2022
Chronic Kidney Disease Stage G4 in a Diabetic Patient Improved by Multi-Disciplinary Treatments Based Upon Literature Search for Therapeutic EvidenceHidekatsu Yanai, Naoki Yamaguchi, Hiroki Adachi
Gastroenterology Research|September 11, 2023
A Significant Effect of Pemafibrate on Hepatic Steatosis and Fibrosis Indexes in Patients With HypertriglyceridemiaHisayuki Katsuyama, Hidekatsu Yanai, Hiroki Adachi, et al.
International Journal of Molecular Sciences|November 11, 2022
Atherogenic Lipoproteins for the Statin Residual Cardiovascular Disease RiskHidekatsu Yanai, Hiroki Adachi, Mariko Hakoshima, et al.
Cardiology Research|March 10, 2023
Glucagon-Like Peptide 1 Receptor Agonists Versus Sodium-Glucose Cotransporter 2 Inhibitors for Atherosclerotic Cardiovascular Disease in Patients With Type 2 DiabetesHidekatsu Yanai, Hiroki Adachi, Mariko Hakoshima, et al.
Journal of Clinical Medicine Research|July 11, 2025
The Long-Term Effects of the Selective Inhibitor of Urate Transporter 1, Dotinurad, on Metabolic Parameters and Renal Function in Japanese Patients With Asymptomatic HyperuricemiaHidekatsu Yanai, Hiroki Adachi, Mariko Hakoshima, et al.
International Journal of Molecular Sciences|April 12, 2022
Molecular Biological and Clinical Understanding of the Statin Residual Cardiovascular Disease Risk and Peroxisome Proliferator-Activated Receptor Alpha Agonists and Ezetimibe for Its TreatmentHidekatsu Yanai, Hiroki Adachi, Mariko Hakoshima, et al.
Biomedicines|February 25, 2023
Urate Transporter 1 Can Be a Therapeutic Target Molecule for Chronic Kidney Disease and Diabetic Kidney Disease: A Retrospective Longitudinal StudyHidekatsu Yanai, Hisayuki Katsuyama, Mariko Hakoshima, et al.
International Journal of Molecular Sciences|March 28, 2026
Molecular Mechanisms and Clinical Evidence Supporting the Four Pillars of Therapy in Diabetic Kidney Disease: Emerging Therapeutic PerspectivesHidekatsu Yanai, Hiroki Adachi, Mariko Hakoshima, et al.
Pageof 8